World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
114
Citations
47673
World Ranking
411
National Ranking
17

Medicine

D-Index
114
Citations
47674
World Ranking
4737
National Ranking
257

Guus F. Rimmelzwaan publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Guus F. Rimmelzwaan sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 407 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Guus F. Rimmelzwaan D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Guus F. Rimmelzwaan sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 114 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Guus F. Rimmelzwaan is affiliated with the University of Veterinary Medicine Hannover, Foundation in Germany. Their research primarily spans medicine, immunology, and microbiology, with a focus on epidemiology, infectious diseases, public health, immunology, and parasitology.

Their scholarly work covers several main research topics, including:

  • Influenza Virus Research Studies
  • Mosquito-borne diseases and control
  • Viral Infections and Vectors
  • Respiratory viral infections research
  • SARS-CoV-2 and COVID-19 Research
  • Vector-borne infectious diseases
  • Immune Cell Function and Interaction

Frequent publication venues for Rimmelzwaan's work include:

  • Frontiers in Immunology
  • Scientific Reports
  • Vaccines
  • Emerging Microbes & Infections
  • bioRxiv (Cold Spring Harbor Laboratory)

Some of their recent papers are:

  • Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals (2022, Nature Medicine)
  • Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease (2021, PLoS ONE)
  • Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63 (2020, Scientific Reports)
  • Tick-Borne Encephalitis Virus: A Quest for Better Vaccines against a Virus on the Rise (2020, Vaccines)
  • Signs of immunosenescence correlate with poor outcome of mRNA COVID-19 vaccination in older adults (2022, Nature Aging)

Rimmelzwaan has collaborated frequently with other researchers, including:

  • Albert Osterhaus
  • Chittappen Kandiyil Prajeeth
  • Giulietta Saletti
  • Wolfgang Baumgärtner
  • Husni Elbahesh

Best Publications

  • Characterization of a Novel Influenza A Virus Hemagglutinin Subtype (H16) Obtained from Black-Headed Gulls

    Ron A. M. Fouchier;Vincent J. Munster;Anders Wallensten;Theo M. Bestebroer

  • Mapping the Antigenic and Genetic Evolution of Influenza Virus

    Derek J. Smith;Derek J. Smith;Alan S. Lapedes;Jan C. de Jong;Theo M. Bestebroer

  • Airborne transmission of influenza A/H5N1 virus between ferrets

    Sander Herfst;Eefje J. A. Schrauwen;Martin Linster;Salin Chutinimitkul

  • Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus

    Eric C J Claas;Albert D M E Osterhaus;Ruud van Beek;Jan C De Jong

  • Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome

    Ron A. M. Fouchier;Peter M. Schneeberger;Frans W. Rozendaal;Jan M. Broekman

  • Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome

    Thijs Kuiken;Ron A.M. Fouchier;Martin Schutten;Guus F. Rimmelzwaan

  • The Global Circulation of Seasonal Influenza A (H3N2) Viruses

    Colin A. Russell;Terry C. Jones;Terry C. Jones;Terry C. Jones;Ian G. Barr;Nancy J. Cox

  • Spatial, Temporal, and Species Variation in Prevalence of Influenza A Viruses in Wild Migratory Birds

    Vincent J Munster;Chantal Baas;Pascal Lexmond;Jonas Waldenström

  • H5N1 Virus Attachment to Lower Respiratory Tract.

    Debby van Riel;Vincent J. Munster;Emmie de Wit;Guus F. Rimmelzwaan

  • Pathogenesis and Transmission of Swine-Origin 2009 A(H1N1) Influenza Virus in Ferrets

    Vincent J. Munster;Emmie de Wit;Judith M. A. van den Brand;Sander Herfst

  • Virology: SARS virus infection of cats and ferrets.

    Byron E. E. Martina;Bart L. Haagmans;Thijs Kuiken;Ron A. M. Fouchier

  • Avian H5N1 Influenza in Cats

    Thijs Kuiken;Guus Rimmelzwaan;Debby van Riel;Geert van Amerongen

  • Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution.

    Björn F. Koel;David F. Burke;Theo M. Bestebroer;Stefan van der Vliet

  • Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals

    Debby van Riel;Vincent J. Munster;Emmie de Wit;Guus F. Rimmelzwaan

  • Detection of Influenza A Viruses from Different Species by PCR Amplification of Conserved Sequences in the Matrix Gene

    Ron A. M. Fouchier;Theo M. Bestebroer;Sander Herfst;Liane Van Der Kemp

  • Influenza B Virus in Seals

    A. D. M. E. Osterhaus;G. F. Rimmelzwaan;B. E. E. Martina;T. M. Bestebroer

  • Clearance of influenza virus from the lung depends on migratory langerin+CD11b− but not plasmacytoid dendritic cells

    Corine H. GeurtsvanKessel;Monique A.M. Willart;Leonie S. van Rijt;Femke Muskens

  • Host species barriers to influenza virus infections.

    Thijs Kuiken;Edward C. Holmes;John McCauley;Guus F. Rimmelzwaan

  • Antibody landscapes after influenza virus infection or vaccination

    J. M. Fonville;J. M. Fonville;J. M. Fonville;S. H. Wilks;S. H. Wilks;S. L. James;S. L. James;A. Fox

  • Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.

    Bart L. Haagmans;Thijs Kuiken;Byron Ee E Martina;Ron Am M Fouchier

  • Immune responses to influenza virus infection.

    J.H.C.M. Kreijtz;R.A.M. Fouchier;G.F. Rimmelzwaan

  • Haemagglutination-inhibiting antibody to influenza virus.

    J C de Jong;A M Palache;W E P Beyer;G F Rimmelzwaan

Frequent Co-Authors

Albert D. M. E. Osterhaus
Albert D. M. E. Osterhaus University of Veterinary Medicine Hannover, Foundation
Ron A. M. Fouchier
Ron A. M. Fouchier Erasmus University Rotterdam
Thijs Kuiken
Thijs Kuiken Erasmus University Rotterdam
Theo M. Bestebroer
Theo M. Bestebroer Erasmus University Rotterdam
Derek J. Smith
Derek J. Smith University of Cambridge
Rogier Bodewes
Rogier Bodewes National Institute for Public Health and the Environment
Marion Koopmans
Marion Koopmans Erasmus University Rotterdam
Vincent J. Munster
Vincent J. Munster National Institutes of Health
Emmie de Wit
Emmie de Wit National Institutes of Health
Adrianus C. M. Boon
Adrianus C. M. Boon Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees can open up diverse career opportunities. Many professionals pursue nursing as a complementary field, leveraging accelerated programs to enter the workforce quickly. For example, an accelerated NP program offers a fast track to becoming a nurse practitioner, blending clinical expertise with immunological knowledge.

Individuals without a nursing background can benefit from online accelerated nursing programs for non nurses, which prepare them efficiently for healthcare roles. These programs are designed with flexibility, allowing students to balance studies and other commitments effectively.

For those seeking entry-level nursing credentials, options like the easiest ABSN program to get into provide a streamlined pathway to earn a Bachelor of Science in Nursing. Similarly, the best easiest LPN programs to get into help prospective Licensed Practical Nurses begin their healthcare careers with minimal barriers.

These related pathways complement immunology careers by enhancing clinical skills and expanding professional options in research, patient care, and public health.

Best Scientists Citing Guus F. Rimmelzwaan

Trending Scientists

Recently Published Articles